|Podcasts|September 16, 2021
Dr. Seth assesses the bleeding risk of Botox treatments in patients who take blood thinners
Author(s)Urology Times staff
“We're not saying a blanket stop for all patients, but I think we do need to be taking each patient as an individual in terms of their backgrounds,” says Jai Seth, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Jai Seth, MD. He discusses onabotulinumtoxinA injection programs as a treatment for urinary incontinence and the bleeding risk associated with these injections for patients who also take blood thinners. Seth is a consultant urological surgeon at St. George’s University hospital, London, UK.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
Practical guide to female pelvic organ–sparing radical cystectomy
3
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
4
Lina Posada Calderon, MD, provides insights on germline BAP1–associated renal cell carcinoma
5